{"F": {"ts_code": "HK.03839", "name": "正大生物", "mkt": "HK", "ccy": "港元", "sw1": "生物技术", "sw2": "生物技术", "sw3": "", "ind": "生物技术", "fin_source": "futu", "market": "主板", "list_date": "20150703", "is_fin": false, "roles": {"fin": false, "commodity": false, "precious": false, "regulated": false, "hard": false, "growth": true}, "province": null, "main_business": "", "introduction": "", "close": 8.685, "pe_ttm": 10.91, "pb": 0.907, "dv_ttm": 0.0, "total_mv": 209063.852235, "trade_date": "20260904", "years": ["最近年报"], "multi_year": false, "period": "最近年报", "gm_series": [14.4], "rev_series": [41.7], "np_series": [2.9], "roe_series": [12.5], "rev_ttm": 41.7, "np_ttm": 1.9, "ocf_ttm": 1.5, "fcf_ttm": null, "fcf_yield": null, "ocf_yield": 7.1, "gm_median": 14.4, "gm_std": null, "gm_stab": null, "gm_chg_2022": null, "npm_median": 6.9, "roe_median": 12.5, "commodity": false, "hard_ratio": 22.8, "fix_assets": 7.8, "goodwill_ratio": null, "pb_calc": null, "capex_dep": null, "interest_debt": null, "debt_ebitda": null, "ebitda": 3.6, "debt_ratio": 33.3, "debt_mv": null, "payout": 0.0, "div_years": 0, "rev_cagr3": null, "np_cagr3": null, "rev_yoy": 74.5, "np_yoy": 165.9, "np_vol": null, "loss_years": 0, "far_share": 54.0, "earn_yield": 9.2, "consensus_n": 0, "fwd_pe": null, "fwd_pe2": null, "fwd_g1": null, "fwd_g2": null, "peg": null, "consensus_disp": null, "mainbz": [], "ret_prev_year": null, "ret_prev2_year": null, "ret_pivot": null, "prev_year": "", "prev2_year": "", "ret_ytd": 19.8, "ret_20": -0.1, "ret_60": -5.1, "ret_120": 48.2, "ret_250": 35.7, "mdd_250": null, "vol_250": null, "pos_52w": 85.6, "eps": 1.036}, "S": {"duration": 24, "pricing": 39, "hard": 36, "bondness": 13}, "label": "中性", "tags": [], "text": {"像什么": ["PE 10.9 倍、股息率 0.0%、毛利率最新年报 14.4%、固定资产占比 23%、资产负债率 33%:四轴都不突出。"], "为什么(不)算钱的替代品": "两条都不占:固定资产占比 23%,毛利率最新年报 14.4%。", "加息期怎么走": "按行业与估值常规看,没有明确的利率方向性。", "四问": [["当前 FCF 能覆盖多少市值?", "经营现金流/市值 7.1%(futu 无资本开支,FCF 按经营现金流 × 0.7 近似)。一般。"], ["能否每年提价而不掉量?", "毛利率最新年报 14.4%。不能。"], ["资产重置成本随通胀涨吗?", "固定资产占总资产 23%。有一些。"], ["估值里多少来自 5 年后的故事?", "按 PE 10.9 倍 粗算,约 54%(1 − 5/PE)。中等。"]], "价格行为": "近一年 36%,现价在 52 周高点的 86%;近 20 / 60 / 120 日 -0% / -5% / 48%。", "行业对照": ["同富途行业「生物技术」83 家中位:PE 24.1 / 股息率 0.0% / 毛利率 71.7% / 固定资产占比 15% / 分红率 0%。", "正大生物:PE 比行业中位低 13.2倍;股息率 与行业中位持平;毛利率 比行业中位低 57.3个百分点;固定资产占比 比行业中位高 8.2个百分点。"]}}